Melanoma staging is a critical tool for communication between physicians and their patients and also assists clinical decision-making and prognostic assessment. It is used for clinical trial design, eligibility, stratification, and analysis. Importantly, it also represents the foundation for reporting in institutional, state, national, and international data registries, which, in turn, facilitate understanding of the broader melanoma landscape.